U.S. Markets open in 1 hr, 9 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 2.92 10:02 AM EST | |
|---|---|---|
| Day High | 3.10 03:59 PM EST |
|
| Range | 0.18 |
| Volume | 1.73 M | |
|---|---|---|
| 30-Day Avg Vol | 2.45 M |
|
| Difference | -29.27% |
| Market Cap | 233.31 M | |
|---|---|---|
| Mkt Cap Chg | 12.04 M |
| Shares Out | 75.26 M | |
|---|---|---|
| % Shrs Traded | 2.31% | |
| 1yr EPS Est | -0.183 |
| 52-Wk Low | 0.84 | |
|---|---|---|
| 52-Wk High | 7.16 |
|
| Range | 6.32 |
| Prev Close | 2.94 2/8/10 | |
|---|---|---|
| Today's Open | 2.96 | |
| Change | 0.68% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 6.43 M |
| Revenue (LFY) | 30.02 M | |
|---|---|---|
| Earnings (LFY) | 2.27 M | |
| Earnings (MRQ) | 770,363.00 | |
| Next Earn Est | -0.022 | |
| Next Earnings | 05/10/2010 |
|
| EPS (TTM) | 0.45 | |
| 1yr EPS Growth | -140.67% |
| P/E Ratio (TTM) | 6.89 | |
|---|---|---|
| P/E Ratio (Fwd) | -16.00 | |
| PEG Ratio | — | |
| Return on Equity | 189.66 | |
| Beta | 2.04 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Immunomedics is focused on developing humanized monoclonal antibodies (MAbs) to treat cancer and other serious diseases. Its lead product, epratuzumab, is in late-stage development for the treatment of ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.022 5/10/10 | — — |
—
—
|
| Last Quarter | 0.004 12/31/09 | 0.01 12/31/09 |
0.006
Beat
|
| 2 Quarters Ago | 0.358 9/30/09 | 0.42 9/30/09 |
0.062
Beat
|
| Quarterly - 12/31/2009 | Annual - 2009 | |
|---|---|---|
| Total Revenue | 5.10 M | 30.02 M |
| Gross Profit | 4.64 M | 28.25 M |
| Operating Income | 621,143.00 | 2.48 M |
| Net Income | 770,363.00 | 2.27 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts